Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

Completed · Not applicable

Conditions studied: Type 2 Diabetes

In brief

The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.

Key facts

Study ID

NCT01072565

Run by

HealthPartners Institute

People needed

91

Starts

2010-02-01

Expected to finish

2012-01-01

Last updated by the study team

2015-11-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subjects ≥18 and ≤75 years of age
• Clinical diagnosis of diabetes
• Diabetes duration ≥ 1 year
• HbA1c ≥7.2%
• Diabetes can be treated with any therapy including medical nutrition therapy alone and any pharmaceutical therapy

You may not qualify if…

• Taken prednisone or cortisone medications in the previous 30 days
• Currently pregnant or planning pregnancy during the study period
• Presence of any severe medical or psychological condition or chronic conditions/infections that in the opinion of the Investigator would compromise the subject's safety or successful participation in the study
• Unable to follow the study protocol
• Unable to speak, read and write in English

Where it is running

• International Diabetes Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.